211 related articles for article (PubMed ID: 17210674)
1. Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor.
Ali A; Christie PT; Grigorieva IV; Harding B; Van Esch H; Ahmed SF; Bitner-Glindzicz M; Blind E; Bloch C; Christin P; Clayton P; Gecz J; Gilbert-Dussardier B; Guillen-Navarro E; Hackett A; Halac I; Hendy GN; Lalloo F; Mache CJ; Mughal Z; Ong AC; Rinat C; Shaw N; Smithson SF; Tolmie J; Weill J; Nesbit MA; Thakker RV
Hum Mol Genet; 2007 Feb; 16(3):265-75. PubMed ID: 17210674
[TBL] [Abstract][Full Text] [Related]
2. Characterization of GATA3 mutations in the hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome.
Nesbit MA; Bowl MR; Harding B; Ali A; Ayala A; Crowe C; Dobbie A; Hampson G; Holdaway I; Levine MA; McWilliams R; Rigden S; Sampson J; Williams AJ; Thakker RV
J Biol Chem; 2004 May; 279(21):22624-34. PubMed ID: 14985365
[TBL] [Abstract][Full Text] [Related]
3. A missense GATA3 mutation, Thr272Ile, causes the hypoparathyroidism, deafness, and renal dysplasia syndrome.
Gaynor KU; Grigorieva IV; Nesbit MA; Cranston T; Gomes T; Gortner L; Thakker RV
J Clin Endocrinol Metab; 2009 Oct; 94(10):3897-904. PubMed ID: 19723756
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of a novel GATA3 mutation in a family with the hypoparathyroidism, deafness, and renal dysplasia syndrome.
Zahirieh A; Nesbit MA; Ali A; Wang K; He N; Stangou M; Bamichas G; Sombolos K; Thakker RV; Pei Y
J Clin Endocrinol Metab; 2005 Apr; 90(4):2445-50. PubMed ID: 15705923
[TBL] [Abstract][Full Text] [Related]
5. Hypoparathyroidism, deafness, and renal dysplasia syndrome: 20 Years after the identification of the first GATA3 mutations.
Lemos MC; Thakker RV
Hum Mutat; 2020 Aug; 41(8):1341-1350. PubMed ID: 32442337
[TBL] [Abstract][Full Text] [Related]
6. Hypoparathyroidism, deafness and renal dysplasia syndrome caused by a
Gonçalves CI; Carriço JN; Omar OM; Abdalla E; Lemos MC
Front Endocrinol (Lausanne); 2023; 14():1207425. PubMed ID: 37600721
[TBL] [Abstract][Full Text] [Related]
7. GATA3 abnormalities and the phenotypic spectrum of HDR syndrome.
Muroya K; Hasegawa T; Ito Y; Nagai T; Isotani H; Iwata Y; Yamamoto K; Fujimoto S; Seishu S; Fukushima Y; Hasegawa Y; Ogata T
J Med Genet; 2001 Jun; 38(6):374-80. PubMed ID: 11389161
[TBL] [Abstract][Full Text] [Related]
8. A novel loss-of-function mutation of GATA3 (p.R299Q) in a Japanese family with Hypoparathyroidism, Deafness, and Renal Dysplasia (HDR) syndrome.
Okawa T; Yoshida M; Usui T; Kudou T; Iwasaki Y; Fukuoka K; Takahashi N; Uehara Y; Oiso Y
BMC Endocr Disord; 2015 Oct; 15():66. PubMed ID: 26514990
[TBL] [Abstract][Full Text] [Related]
9. GATA3 mutation in a family with hypoparathyroidism, deafness and renal dysplasia syndrome.
Zhu ZY; Zhou QL; Ni SN; Gu W
World J Pediatr; 2014 Aug; 10(3):278-80. PubMed ID: 25124981
[TBL] [Abstract][Full Text] [Related]
10. Clinical and mutational spectrum of hypoparathyroidism, deafness and renal dysplasia syndrome.
Belge H; Dahan K; Cambier JF; Benoit V; Morelle J; Bloch J; Vanhille P; Pirson Y; Demoulin N
Nephrol Dial Transplant; 2017 May; 32(5):830-837. PubMed ID: 27387476
[TBL] [Abstract][Full Text] [Related]
11. GATA3 haplo-insufficiency causes human HDR syndrome.
Van Esch H; Groenen P; Nesbit MA; Schuffenhauer S; Lichtner P; Vanderlinden G; Harding B; Beetz R; Bilous RW; Holdaway I; Shaw NJ; Fryns JP; Van de Ven W; Thakker RV; Devriendt K
Nature; 2000 Jul; 406(6794):419-22. PubMed ID: 10935639
[TBL] [Abstract][Full Text] [Related]
12. Identification of three novel mutations in the GATA3 gene responsible for familial hypoparathyroidism and deafness in the Chinese population.
Chiu WY; Chen HW; Chao HW; Yann LT; Tsai KS
J Clin Endocrinol Metab; 2006 Nov; 91(11):4587-92. PubMed ID: 16912130
[TBL] [Abstract][Full Text] [Related]
13. Clinical Auditory Phenotypes Associated with
Wang L; Lin QF; Wang HY; Guan J; Lan L; Xie LY; Yu L; Yang J; Zhao C; Liang JL; Zhou HL; Yang HM; Xiong WP; Zhang QJ; Wang DY; Wang QJ
Chin Med J (Engl); 2017 Mar; 130(6):703-709. PubMed ID: 28303854
[TBL] [Abstract][Full Text] [Related]
14. A novel GATA3 nonsense mutation in a newly diagnosed adult patient of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome.
Nanba K; Usui T; Nakamura M; Toyota Y; Hirota K; Tamanaha T; Kawashima ST; Nakao K; Yuno A; Tagami T; Naruse M; Shimatsu A
Endocr Pract; 2013; 19(1):e17-20. PubMed ID: 23186964
[TBL] [Abstract][Full Text] [Related]
15. Novel mutation in the gene encoding the GATA3 transcription factor in a Spanish familial case of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome with female genital tract malformations.
Hernández AM; Villamar M; Roselló L; Moreno-Pelayo MA; Moreno F; Del Castillo I
Am J Med Genet A; 2007 Apr; 143A(7):757-62. PubMed ID: 17309062
[No Abstract] [Full Text] [Related]
16. The first Korean case of HDR syndrome confirmed by clinical and molecular investigation.
Cheon CK; Kim GH; Yoo HW
Yonsei Med J; 2015 Jan; 56(1):300-3. PubMed ID: 25510779
[TBL] [Abstract][Full Text] [Related]
17. HDR syndrome: a novel "de novo" mutation in GATA3 gene.
Ferraris S; Del Monaco AG; Garelli E; Carando A; De Vito B; Pappi P; Lala R; Ponzone A
Am J Med Genet A; 2009 Feb; 149A(4):770-5. PubMed ID: 19248180
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel insertion mutation in GATA3 with HDR syndrome.
Mino Y; Kuwahara T; Mannami T; Shioji K; Ono K; Iwai N
Clin Exp Nephrol; 2005 Mar; 9(1):58-61. PubMed ID: 15830275
[TBL] [Abstract][Full Text] [Related]
19. GATA3 mutations found in breast cancers may be associated with aberrant nuclear localization, reduced transactivation and cell invasiveness.
Gaynor KU; Grigorieva IV; Allen MD; Esapa CT; Head RA; Gopinath P; Christie PT; Nesbit MA; Jones JL; Thakker RV
Horm Cancer; 2013 Jun; 4(3):123-39. PubMed ID: 23435732
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of the GATA3 gene in five Japanese patients with HDR syndrome.
Nakamura A; Fujiwara F; Hasegawa Y; Ishizu K; Mabe A; Nakagawa H; Nagasaki K; Jo W; Tajima T
Endocr J; 2011; 58(2):123-30. PubMed ID: 21157112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
